Zileuton 64980-0206-12
- Manufacturer
- Rising Pharma Holdings, Inc.
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- March 21, 2017
- Listing Expires
- December 31, 2026
- Application
- ANDA204929
Need to source Zileuton? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Zileuton | 600 mg/1 |
Drug Class
5-Lipoxygenase Inhibitor [EPC]5-Lipoxygenase Inhibitor [EPC]5-Lipoxygenase Inhibitors [MoA]
Selected Package
64980-0206-12Selected120 TABLET, EXTENDED RELEASE in 1 BOTTLE (64980-206-12)